Edition:
United States

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

162.36USD
25 May 2017
Change (% chg)

-- (--)
Prev Close
$162.36
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
427,967
52-wk High
$199.22
52-wk Low
$114.54

MCK.N

Chart for MCK.N

About

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty... (more)

Overall

Beta: 1.15
Market Cap(Mil.): $34,242.13
Shares Outstanding(Mil.): 210.90
Dividend: 0.28
Yield (%): 0.69

Financials

  MCK.N Industry Sector
P/E (TTM): 6.80 21.66 41.26
EPS (TTM): 23.89 -- --
ROI: 24.09 9.14 53.07
ROE: 51.89 10.65 60.75

BRIEF-McKesson sets regular quarterly dividend of $0.28/share

* Sets regular quarterly dividend of $0.28/share Source text for Eikon: Further company coverage:

May 24 2017

Drug distributor McKesson's upbeat forecast sends shares soaring

McKesson Corp reported a higher-than-expected quarterly profit and forecast an upbeat full-year earnings, easing concerns about the drug wholesaler's struggles with moderating branded drug price increases and falling prices for generics.

May 18 2017

UPDATE 2-Drug distributor McKesson's upbeat forecast sends shares soaring

May 18 McKesson Corp reported a higher-than-expected quarterly profit and forecast an upbeat full-year earnings, easing concerns about the drug wholesaler's struggles with moderating branded drug price increases and falling prices for generics.

May 18 2017

Drug distributor McKesson's quarterly revenue rises 4.4 pct

May 18 Drug wholesaler McKesson Corp reported a 4.4 percent rise in quarterly revenue, helped by strength in its pharmaceutical distribution and services business.

May 18 2017

BRIEF-Uniprix shareholders approve at 95% Mckesson Canada's bid to acquire Uniprix

* At shareholder meeting, shareholders approved 95% to Mckesson Canada's bid to acquire all outstanding shares of Uniprix Source text for Eikon: Further company coverage:

May 16 2017

BRIEF-Mckesson anticipates recording pre-tax gain of about $2.9 to $3.5 bln in Q4

* As a result of net gain from transaction, co to add about $10.70-$12.35 in Q4 GAAP earnings per share from continuing operations

Mar 02 2017

Fitch Rates McKesson's EUR and GBP Notes 'BBB+'; Outlook Stable

(The following statement was released by the rating agency) NEW YORK, February 13 (Fitch) Fitch Ratings has assigned 'BBB+' ratings to the EUR and GBP denominated senior unsecured notes issued by McKesson Corp. (NYSE: MCK). A full list of ratings follows at the end of the release. KEY RATING DRIVERS Stable Operations, Low Margins The credit profiles of MCK and its peers benefit from stable operating profiles and consistent cash generation. Steady pharmaceutical demand, an oligopolistic drug

Feb 13 2017

Thoma Bravo explores sale of Global Health Exchange-sources

Buyout firm Thoma Bravo LLC is exploring a sale of Global Health Exchange (GHX), a software company that helps track medical and surgical supplies that could be worth as much as $1.3 billion, including debt, according to people familiar with the matter.

Jan 31 2017

Thoma Bravo explores sale of Global Health Exchange-sources

Jan 31 Buyout firm Thoma Bravo LLC is exploring a sale of Global Health Exchange (GHX), a software company that helps track medical and surgical supplies that could be worth as much as $1.3 billion, including debt, according to people familiar with the matter.

Jan 31 2017

BRIEF-Mckesson announces purchase of CoverMyMeds

* McKesson announces purchase of CoverMyMeds, a Francisco Partners portfolio company

Jan 26 2017

More From Around the Web

Earnings vs. Estimates